MX9704336A - Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus. - Google Patents
Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.Info
- Publication number
- MX9704336A MX9704336A MX9704336A MX9704336A MX9704336A MX 9704336 A MX9704336 A MX 9704336A MX 9704336 A MX9704336 A MX 9704336A MX 9704336 A MX9704336 A MX 9704336A MX 9704336 A MX9704336 A MX 9704336A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- prophylaxis
- antiviral agents
- herpesvirus infections
- aminopurine
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 3
- 208000029433 Herpesviridae infectious disease Diseases 0.000 title 1
- 150000005018 aminopurines Chemical class 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000032420 Latent Infection Diseases 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- -1 phosphate ester Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un método para el tratamiento de infeccion latente de herpesvirus en mamíferos, incluyendo los seres humanos, el cual método comprende administrar al mamífero en necesidad de dicho tratamiento, una cantidad efectiva de un compuesto de la formula (A): o un bioprecursor, o una sal farmacéuticamente aceptable, ésterfosfato y/o derivado de acilo de cualquiera de los anteriores.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9425012.3 | 1994-12-12 | ||
| GBGB9425012.3A GB9425012D0 (en) | 1994-12-12 | 1994-12-12 | Pharmaceuticals |
| GB9506663.5 | 1995-03-31 | ||
| GBGB9506663.5A GB9506663D0 (en) | 1995-03-31 | 1995-03-31 | Pharmaceuticals |
| GBGB9517308.4A GB9517308D0 (en) | 1995-08-24 | 1995-08-24 | Pharmaceuticals |
| GB9517308.4 | 1995-08-24 | ||
| US08/522,790 US5840763A (en) | 1994-12-12 | 1995-09-01 | Treatment of a latent infection of herpes viruses |
| PCT/EP1995/004692 WO1996018396A1 (en) | 1994-12-12 | 1995-11-23 | Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9704336A true MX9704336A (es) | 1997-09-30 |
| MXPA97004336A MXPA97004336A (es) | 1998-07-03 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE165004T1 (de) | Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung | |
| EP0154344A3 (en) | Antiviral pharmaceutical preparations and methods for their use | |
| CA2197319A1 (en) | Lipid analogs for treating viral infections | |
| MY117892A (en) | Therapeutic compounds | |
| CA2207503A1 (en) | Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections | |
| NZ241121A (en) | Antiviral composition for treating herpes comprising a nucleoside analog & a ribonucleotide reductase inhibiting peptide derivative | |
| HU901252D0 (en) | Process for manufacturing of pharmaceutical compositions comprising purine derivatives | |
| AU7806187A (en) | Sulphonamide derivatives for the treatment and prevention of viral diseases | |
| AU8447991A (en) | Antineoplastic effect potentiator and antineoplastic agent | |
| HUP9900945A2 (hu) | Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában | |
| DK0728002T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| DK0728001T3 (da) | Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 6-infektioner | |
| NO954390D0 (no) | Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner | |
| TR199700921T1 (xx) | �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�. | |
| MX9307639A (es) | Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido. | |
| MX9605153A (es) | Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas. |